Filter
141
Text search:
generics
Featured
Recommendations
14
New Publications
40
Language
Document type
No document type
65
Studies & Reports
41
Guidelines
22
Strategic & Response Plan
6
Manuals
4
Situation Updates
2
Infographics
1
Countries / Regions
Global
9
India
5
Kenya
5
Ghana
4
South Africa
4
Ukraine
4
Philippines
3
Tanzania
3
Namibia
3
Sierra Leone
2
Nigeria
2
Senegal
2
Ethiopia
2
Uganda
2
Haiti
2
Rwanda
2
Indonesia
2
Malawi
2
Lesotho
2
Latin America and the Carribbean
2
Western and Central Europe
2
Burkina Faso
1
Zimbabwe
1
Germany
1
Syria
1
Eswatini/ Swaziland
1
Brazil
1
Botswana
1
Myanmar / Burma
1
East and Southern Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Albania
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
55
Clinical Guidelines
20
Public Health
10
Pharmacy & Technologies
8
Women & Child Health
2
Toolboxes
Pharmacy
23
HIV
19
AMR
19
NCDs
12
COVID-19
5
TB
4
Mental Health
3
Global Health Education
3
Health Financing Toolbox
3
Conflict
2
Refugee
2
Planetary Health
2
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases. The evaluation combines both quantitative and qualitative anal
...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand
...
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r
...
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
Background
Access to medicines is important for long‐term care of cardiovascular diseases and hypertension. This study provides a cross‐country assessment of availability, prices, and affordability of cardiovascular disease and hypertension medicines to identify areas for improvement in access
...
An evaluation of the prescribing patterns for under-five patients at a Tertiary Paediatric Hospital in Sierra Leone. J Basic Clin Pharma 2015;6:109-14.
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and
...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those
...
The "Global NCD action plan" provides a road map and a menu of policy options for countries to take in order to attain the 9 voluntary global targets, including that of a 25% relative reduction in premature mortality from cardiovascular diseases, cancer, diabetes or chronic respiratory diseases by 2
...
